Ken Cohen

Bio

Kenneth M. Cohen is an independent adviser to entrepreneurs, companies, and  investors, primarily in the life sciences, and a lecturer at the Fowler College of Business  at San Diego State University, where he teaches multinational business management.  Ken was previously Co-founder, President and CEO of Somaxon Pharmaceuticals, a  specialty pharmaceutical company. He was President and CEO of Synbiotics  Corporation, a veterinary diagnostics company, and was Executive Vice President and  COO for Canji, a gene-therapy company, until its acquisition by Schering-Plough Corp.  He served as Vice President of Business Affairs at Argus Pharmaceuticals and VP of  Marketing & Business Development for LifeCell Corporation. Ken held numerous  positions during 10 years at Eli Lilly and Company, including Director of Business  Planning for Medical Instrument Systems, which became Guidant Corp., and managed  the launch of Prozac®, one of the most successful pharmaceutical products in history.  

Ken received his A.B. degree from Dartmouth College and an M.B.A. from the Wharton  School. In 1999, in recognition of his contributions to French-American business cooperation, the President of France named Ken a Chevalier of the National Order of  Merit. 

Mr. Cohen has consulted to and been a director of multiple pharmaceutical, medical  device, and biotechnology companies. Ken is presently Chair-elect of the Board of the  San Diego Blood Bank, and Trustee and Chairman Emeritus of the San Diego Humane  Society.